Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1024 | 958 | 1024 | 1094 | 1387 | 2228 |
Fund Return | 2.38% | -4.18% | 2.38% | 3.03% | 6.76% | 8.34% |
Place in category | 219 | 348 | 219 | 197 | 185 | 117 |
% in Category | 34 | 48 | 34 | 36 | 36 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC American Index Fund Retail Acc | 17.34B | 27.03 | 11.92 | 15.17 | ||
HSBC American Index Fund Retail Inc | 17.34B | 27.01 | 12.40 | 15.30 | ||
HSFund Institutional Accumulation | 17.34B | 27.15 | 12.05 | 15.33 | ||
HSBC American Index Fund Income C | 17.34B | 26.93 | 11.31 | 15.12 | ||
HSBC American Index Fund Accumulati | 17.34B | 26.95 | 11.32 | 15.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
iShares Continental Europe Eq D Acc | 6.54B | 2.29 | 3.11 | 8.28 | ||
GB00BJL5BS14 | 6.54B | 2.29 | 3.12 | 8.29 | ||
Continental European Flexible Fundg | 18.62M | 4.42 | 0.28 | 12.22 | ||
Fidelity European Acc | 535.01M | -0.30 | 4.47 | 8.78 | ||
Fidelity European Fund W Acc | 2.79B | 0.37 | 5.25 | 9.60 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 3.35 | 732.40 | -2.09% | |
SAP | DE0007164600 | 3.25 | 256.750 | +0.29% | |
Novo Nordisk B | DK0062498333 | 3.23 | 573.6 | +4.04% | |
Nestle | CH0038863350 | 2.57 | 74.74 | +0.38% | |
Novartis | CH0012005267 | 2.36 | 89.36 | +0.15% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review